Literature DB >> 26837737

Questions and Answers About Myostatin, GDF11, and the Aging Heart.

Elizabeth M McNally1.   

Abstract

Entities:  

Keywords:  Editorials; GDF11 protein, rat; aging; cardiomegaly; heart; myostatin

Mesh：

Substances：

Year:  2016        PMID： 26837737      PMCID： PMC4742361          DOI： 10.1161/CIRCRESAHA.115.307861

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  13 in total

1.  Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.

Authors:  Tommaso Poggioli; Ana Vujic; Peiguo Yang; Claudio Macias-Trevino; Aysu Uygur; Francesco S Loffredo; James R Pancoast; Miook Cho; Jill Goldstein; Rachel M Tandias; Emilia Gonzalez; Ryan G Walker; Thomas B Thompson; Amy J Wagers; Yick W Fong; Richard T Lee
Journal:  Circ Res       Date:  2015-10-21       Impact factor: 17.367

2.  Targeting a new regulator of erythropoiesis to alleviate anemia.

Authors:  Robert F Paulson
Journal:  Nat Med       Date:  2014-04       Impact factor: 53.440

Review 3.  Myostatin and the control of skeletal muscle mass.

Authors:  S J Lee; A C McPherron
Journal:  Curr Opin Genet Dev       Date:  1999-10       Impact factor: 5.578

4.  Myostatin does not regulate cardiac hypertrophy or fibrosis.

Authors:  Ronald D Cohn; Hsin-Yueh Liang; Reena Shetty; Theodore Abraham; Kathryn R Wagner
Journal:  Neuromuscul Disord       Date:  2007-03-02       Impact factor: 4.296

5.  Suppression of body fat accumulation in myostatin-deficient mice.

Authors:  Alexandra C McPherron; Se-Jin Lee
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  GDF11 does not rescue aging-related pathological hypertrophy.

Authors:  Shavonn C Smith; Xiaoxiao Zhang; Xiaoying Zhang; Polina Gross; Timothy Starosta; Sadia Mohsin; Michael Franti; Priyanka Gupta; David Hayes; Maria Myzithras; Julius Kahn; James Tanner; Steven M Weldon; Ashraf Khalil; Xinji Guo; Abdelkarim Sabri; Xiongwen Chen; Scott MacDonnell; Steven R Houser
Journal:  Circ Res       Date:  2015-09-17       Impact factor: 17.367

Review 7.  Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity.

Authors:  Michael J Conboy; Irina M Conboy; Thomas A Rando
Journal:  Aging Cell       Date:  2013-04-10       Impact factor: 9.304

8.  Genomic structure and genetic drift in C57BL/6 congenic metabolic mutant mice.

Authors:  Alvin J O Almodovar; Rita J Luther; Caron L Stonebrook; Philip A Wood
Journal:  Mol Genet Metab       Date:  2013-07-02       Impact factor: 4.797

9.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

10.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582
View more
  10 in total

1.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

2.  Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.

Authors:  V K Yang; J E Rush; S Bhasin; A J Wagers; R T Lee
Journal:  J Vet Cardiol       Date:  2019-09-01       Impact factor: 1.701

Review 3.  Plasma-Based Strategies for Therapeutic Modulation of Brain Aging.

Authors:  Viktoria Kheifets; Steven P Braithwaite
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

4.  Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.

Authors:  Marissa J Schafer; Elizabeth J Atkinson; Patrick M Vanderboom; Brian Kotajarvi; Thomas A White; Matthew M Moore; Charles J Bruce; Kevin L Greason; Rakesh M Suri; Sundeep Khosla; Jordan D Miller; H Robert Bergen; Nathan K LeBrasseur
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

5.  GDF11/BMP11 as a novel tumor marker for liver cancer.

Authors:  Yong-Hui Zhang; Lian-Hong Pan; Yi Pang; Jin-Xin Yang; Meng-Jia Lv; Feng Liu; Xue-Feng Qu; Xin-Xin Chen; Hua-Jun Gong; Dan Liu; Yong Wei
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

Review 6.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

7.  Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?

Authors:  Shavonn C Harper; Andrew Brack; Scott MacDonnell; Michael Franti; Bradley B Olwin; Beth A Bailey; Michael A Rudnicki; Steven R Houser
Journal:  Circ Res       Date:  2016-04-01       Impact factor: 17.367

Review 8.  Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Authors:  Ryan G Walker; Tommaso Poggioli; Lida Katsimpardi; Sean M Buchanan; Juhyun Oh; Sam Wattrus; Bettina Heidecker; Yick W Fong; Lee L Rubin; Peter Ganz; Thomas B Thompson; Amy J Wagers; Richard T Lee
Journal:  Circ Res       Date:  2016-04-01       Impact factor: 17.367

9.  Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity.

Authors:  Lin Chen; Guangjin Luo; Yameng Liu; Hairuo Lin; Cankun Zheng; Dongxiao Xie; Yingqi Zhu; Lu Chen; Xiaoxia Huang; Donghong Hu; Jiahe Xie; Zhenhuan Chen; Wangjun Liao; Jianping Bin; Qiancheng Wang; Yulin Liao
Journal:  Cell Death Dis       Date:  2021-07-02       Impact factor: 8.469

Review 10.  Role of growth differentiation factor 11 in development, physiology and disease.

Authors:  Yonghui Zhang; Yong Wei; Dan Liu; Feng Liu; Xiaoshan Li; Lianhong Pan; Yi Pang; Dilong Chen
Journal:  Oncotarget       Date:  2017-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.